Profile
William F.
Hahne worked as an Executive Director of Clinical Research at Eisai, Inc. from 1997 to 2002.
He then served as a Vice President of Medical at Vion Pharmaceuticals, Inc. After that, he held the position of VP of Clinical Development & Medical Affairs at Imunon, Inc. from 2006 to 2007.
Prior to that, he was a Vice President of Clinical Development at CuraGen Corp.
from 2003 to 2005.
He also worked as a Vice President of Clinical Development at CuraGen Corp.
and as a Vice President of Clinical Research at Bio-Path Holdings, Inc. Dr. Hahne completed his undergraduate degree at Grinnell College and obtained a doctorate degree from Cornell University.
Former positions of William Hahne
| Companies | Position | End |
|---|---|---|
| IMUNON, INC. | Chief Tech/Sci/R&D Officer | 01/12/2007 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Chief Tech/Sci/R&D Officer | 01/01/2005 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Chief Tech/Sci/R&D Officer | 01/01/2002 |
| BIO-PATH HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small molecule anticancer compounds | Chief Tech/Sci/R&D Officer | - |
Training of William Hahne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small molecule anticancer compounds | Health Technology |
Imunon, Inc.
Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company, which focuses on developing therapeutic products | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Grinnell College
Grinnell College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- William Hahne
















